Researchers have introduced a new approach to treat Alzheimer’s disease. Alzheimer’s disease is the sixth leading cause of death among in older adults. The exact causes of Alzheimer’s disease are still unknown, but several factors are presumed to be causative agents. Among these, the aggregation of amyloid-? peptide has been implicated as a contributor to the formation of neuritic plaques, which are pathological hallmarks of Alzheimer’s disease.